Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for PsychosisCassandra M.J. WannanBarnaby Nelsonet al.2024Schizophrenia Bulletin
Differential Expression of Anomalous Self-Experiences in Spontaneous Speech in Clinical High-Risk and Early-Course Psychosis Quantified by Natural Language ProcessingAgrima SrivastavaAlexandria Selloniet al.2023Biological Psychiatry
The SPEAK study rationale and design: A linguistic corpus-based approach to understanding thought disorderJohanna BayerJessica Sparket al.2023Schizophrenia Research